PortfoliosLab logo

Ambrx Biopharma Inc. (AMAM)

Equity · Currency in USD · Last updated Feb 4, 2023

Company Info

ISINUS02290A1025
CUSIP02290A102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.80
Year Range$0.41 - $5.12
EMA (50)$1.77
EMA (200)$2.48
Average Volume$4.63M
Market Capitalization$69.51M

AMAMShare Price Chart


Loading data...

AMAMPerformance

The chart shows the growth of $10,000 invested in Ambrx Biopharma Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,056 for a total return of roughly -89.44%. All prices are adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%150.00%200.00%OctoberNovemberDecember2023February
14.66%
4.27%
AMAM (Ambrx Biopharma Inc.)
Benchmark (^GSPC)

AMAMCompare to other instruments

Search for stocks, ETFs, and funds to compare with AMAM

Ambrx Biopharma Inc.

AMAMReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-13.04%8.17%
YTD-20.70%7.73%
6M-23.40%-0.37%
1Y-60.78%-9.87%
5Y-74.89%-0.44%
10Y-74.89%-0.44%

AMAMMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-16.74%
2022-40.65%-34.55%-9.54%-49.85%363.27%

AMAMSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Ambrx Biopharma Inc. Sharpe ratio is -0.06. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.40-1.20-1.00-0.80-0.60-0.40-0.200.00OctoberNovemberDecember2023February
-0.06
-0.41
AMAM (Ambrx Biopharma Inc.)
Benchmark (^GSPC)

AMAMDividend History


Ambrx Biopharma Inc. doesn't pay dividends

AMAMDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%OctoberNovemberDecember2023February
-92.01%
-13.76%
AMAM (Ambrx Biopharma Inc.)
Benchmark (^GSPC)

AMAMWorst Drawdowns

The table below shows the maximum drawdowns of the Ambrx Biopharma Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Ambrx Biopharma Inc. is 98.18%, recorded on Dec 8, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.18%Jul 14, 2021356Dec 8, 2022
-6.45%Jun 21, 20212Jun 22, 20213Jun 25, 20215
-4.08%Jul 1, 20211Jul 1, 20212Jul 6, 20213
-2.47%Jul 9, 20212Jul 12, 20211Jul 13, 20213
-2.27%Jun 28, 20211Jun 28, 20211Jun 29, 20212
-0.15%Jul 7, 20211Jul 7, 20211Jul 8, 20212

AMAMVolatility Chart

Current Ambrx Biopharma Inc. volatility is 96.41%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%200.00%400.00%600.00%800.00%1,000.00%1,200.00%1,400.00%OctoberNovemberDecember2023February
96.41%
16.33%
AMAM (Ambrx Biopharma Inc.)
Benchmark (^GSPC)